Cavitation Technologies CVAT

Cavitation Technologies reports $0 revenue and $208,000 net loss

Form
10-Q
Filed
Importance
Notable
  1. Revenue: $0 for the three months ended Sep 30, 2026
  2. Net loss: $208,000 for the three months ended Sep 30, 2026
  3. Cash and equivalents: $94,000 at Sep 30, 2026

Written from the 10-Q on EDGAR. Check the filing before you rely on it.

Get an email when Cavitation Technologies files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

What changed since last quarter

Compared with the 10-Q for the period ended Mar 31, 2026.

Key numbers from the XBRL in this filing and the previous one.
This filingPreviousChange vs prior 10-Q
Revenue$0−$3K+100%
Operating income and margin−$165K−$434K+62%
Net income−$208K−$451K+54%
Operating cash flow−$128K−$228K+44%
Cash$94K$17K+453%

Similar companies

Companies of similar size in SIC 700 and related industry codes: the same peer list as the financial tables.